In Vitro Co-Culture Models of Breast Cancer Metastatic Progression towards Bone

Advanced breast cancer frequently metastasizes to bone through a multistep process involving the detachment of cells from the primary tumor, their intravasation into the bloodstream, adhesion to the endothelium and extravasation into the bone, culminating with the establishment of a vicious cycle causing extensive bone lysis. In recent years, the crosstalk between tumor cells and secondary organs microenvironment is gaining much attention, being indicated as a crucial aspect in all metastatic steps. To investigate the complex interrelation between the tumor and the microenvironment, both in vitro and in vivo models have been exploited. In vitro models have some advantages over in vivo, mainly the possibility to thoroughly dissect in controlled conditions and with only human cells the cellular and molecular mechanisms underlying the metastatic progression. In this article we will review the main results deriving from in vitro co-culture models, describing mechanisms activated in the crosstalk between breast cancer and bone cells which drive the different metastatic steps.

[1]  D. Wilson Tissue , 2009, The Lancet.

[2]  M. Kerin,et al.  Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells , 2009, International journal of cancer.

[3]  Simone Bersini,et al.  Human in vitro 3D co-culture model to engineer vascularized bone-mimicking tissues combining computational tools and statistical experimental approach. , 2016, Biomaterials.

[4]  Mina J. Bissell,et al.  The perivascular niche regulates breast tumor dormancy , 2013, Nature Cell Biology.

[5]  Robert A. Weinberg,et al.  Tumor Metastasis: Molecular Insights and Evolving Paradigms , 2011, Cell.

[6]  Wenshu Wu,et al.  SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis , 2011, Molecular Cancer.

[7]  T. Guise,et al.  Cancer-associated muscle weakness: What's bone got to do with it? , 2015, BoneKEy reports.

[8]  Yu-Chi Chen,et al.  Breast cancer metastasis to the bone: mechanisms of bone loss , 2010, Breast Cancer Research.

[9]  Z. Bao,et al.  Expression of MacMARCKS Restores Cell Adhesion to ICAM-1-Coated Surface , 2000, Cell adhesion and communication.

[10]  I. Holen,et al.  Human breast cancer bone metastasis in vitro and in vivo: a novel 3D model system for studies of tumour cell-bone cell interactions , 2015, Clinical & Experimental Metastasis.

[11]  A. Magliocco,et al.  Role of Src in breast cancer cell migration and invasion in a breast cell/bone-derived cell microenvironment , 2012, Breast Cancer Research and Treatment.

[12]  Matteo Moretti,et al.  In vitro models of the metastatic cascade: from local invasion to extravasation. , 2014, Drug discovery today.

[13]  J. Mitchison Cell Biology , 1964, Nature.

[14]  S. Bersini,et al.  A 3D vascularized bone remodeling model combining osteoblasts and osteoclasts in a CaP nanoparticle-enriched matrix. , 2016, Nanomedicine.

[15]  A. Fatatis,et al.  Osteoblasts modulate Ca2+ signaling in bone-metastatic prostate and breast cancer cells , 2009, Clinical & Experimental Metastasis.

[16]  Arnaud Scherberich,et al.  Transcriptional regulation of tenascin‐W by TGF‐beta signaling in the bone metastatic niche of breast cancer cells , 2015, International journal of cancer.

[17]  Yasuhiro Kobayashi,et al.  Regulatory mechanism of osteoclastogenesis by RANKL and Wnt signals. , 2011, Frontiers in bioscience.

[18]  N. Kosaka,et al.  Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells , 2014, Science Signaling.

[19]  A. Ridley,et al.  Crossing the endothelial barrier during metastasis , 2013, Nature Reviews Cancer.

[20]  R. Hynes,et al.  Platelets guide the formation of early metastatic niches , 2014, Proceedings of the National Academy of Sciences.

[21]  A. Axel,et al.  Interleukin‐6 is a potent growth factor for ER‐α‐positive human breast cancer , 2007 .

[22]  Peter C. Searson,et al.  In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform , 2016, Front. Bioeng. Biotechnol..

[23]  R. Girgert,et al.  Estrogen receptor β selective agonists reduce invasiveness of triple-negative breast cancer cells. , 2015, International journal of oncology.

[24]  K Yano,et al.  Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Yan Sun,et al.  ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFβ Signaling Pathway. , 2015, Cancer research.

[26]  M. Junttila,et al.  Influence of tumour micro-environment heterogeneity on therapeutic response , 2013, Nature.

[27]  A. Tutt,et al.  A novel model of dormancy for bone metastatic breast cancer cells. , 2013, Cancer research.

[28]  M. Smyth,et al.  The pre-metastatic niche: finding common ground , 2013, Cancer and Metastasis Reviews.

[29]  J. Gong,et al.  Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer , 2011, Molecular and Cellular Biochemistry.

[30]  J. Canon,et al.  RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model , 2012, Breast Cancer Research and Treatment.

[31]  A. Sullivan,et al.  Comparative survival in tissue culture of normal and neoplastic human cells exposed to adriamycin. , 1974, Cancer research.

[32]  R. Weinberg,et al.  Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells. , 2016, Cancer discovery.

[33]  C. Rochlitz,et al.  Global Gene Expression Analysis of the Interaction between Cancer Cells and Osteoblasts to Predict Bone Metastasis in Breast Cancer , 2012, PloS one.

[34]  Christopher S. Chen,et al.  Deconstructing Dimensionality , 2013, Science.

[35]  Abhay Pandit,et al.  Recreating complex pathophysiologies in vitro with extracellular matrix surrogates for anticancer therapeutics screening. , 2016, Drug discovery today.

[36]  F. Jakob,et al.  Breast carcinoma cells modulate the chemoattractive activity of human bone marrow‐derived mesenchymal stromal cells by interfering with CXCL12 , 2015, International journal of cancer.

[37]  G. Baldini,et al.  Breast adenocarcinoma MCF-7 cell line induces spontaneous osteoclastogenesis via a RANK-ligand-dependent pathway. , 2008, Acta histochemica.

[38]  S. Stock,et al.  Regulation of Breast Cancer-induced Bone Lesions by β-Catenin Protein Signaling* , 2011, The Journal of Biological Chemistry.

[39]  T. Nagasawa CXCL12/SDF-1 and CXCR4 , 2015, Front. Immunol..

[40]  K. Horas,et al.  Animal Models for Breast Cancer Metastasis to Bone: Opportunities and Limitations , 2015, Cancer investigation.

[41]  D. Amadori,et al.  CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems. , 2014, Bone.

[42]  L. Beex,et al.  Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasis , 1991, Breast Cancer Research and Treatment.

[43]  T. Oskarsson,et al.  Extracellular matrix players in metastatic niches , 2012, The EMBO journal.

[44]  C. Contag,et al.  Animal models of bone metastasis , 2003, Cancer.

[45]  R. Weinberg,et al.  A Perspective on Cancer Cell Metastasis , 2011, Science.

[46]  H. Putter,et al.  Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials , 2015, European journal of cancer.

[47]  V. Fowler,et al.  Osteoblasts produce monocyte chemoattractant protein-1 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissue. , 2005, Bone.

[48]  E. Vogler,et al.  In Vitro Mimics of Bone Remodeling and the Vicious Cycle of Cancer in Bone , 2014, Journal of cellular physiology.

[49]  Yibin Kang,et al.  IMPLICATIONS FOR OSTEOLYTIC BONE METASTASES * , 2007, Journal of Biological Chemistry.

[50]  C. Polychronakos,et al.  The kisspeptin (KiSS-1)/GPR54 system in cancer biology. , 2008, Cancer treatment reviews.

[51]  A. Mastro,et al.  Dormancy and growth of metastatic breast cancer cells in a bone-like microenvironment , 2015, Clinical & Experimental Metastasis.

[52]  Steven J. Greco,et al.  Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. , 2011, Cancer research.

[53]  J. Wesseling,et al.  A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. , 1996, Molecular biology of the cell.

[54]  A. Scherberich,et al.  Murine tenascin-W: a novel mammalian tenascin expressed in kidney and at sites of bone and smooth muscle development , 2004, Journal of Cell Science.

[55]  L. Suva,et al.  Osteoprotegrin and the bone homing and colonization potential of breast cancer cells , 2008, Journal of cellular biochemistry.

[56]  E. C. Weir,et al.  A Role for Cell-Surface CSF-1 in Osteoblast-mediated Osteoclastogenesis , 2002, Calcified Tissue International.

[57]  B. Paradiso,et al.  The stimulation of A(3) adenosine receptors reduces bone-residing breast cancer in a rat preclinical model. , 2013, European journal of cancer.

[58]  K. Pienta,et al.  Cancer cells homing to bone: the significance of chemotaxis and cell adhesion. , 2004, Cancer treatment and research.

[59]  K. Packman,et al.  Mesenchymal Stem Cells in Early Entry of Breast Cancer into Bone Marrow , 2008, PloS one.

[60]  G. Emons,et al.  Kisspeptin-10 inhibits bone-directed migration of GPR54-positive breast cancer cells: Evidence for a dose-window effect. , 2010, Gynecologic oncology.

[61]  M. Suzui,et al.  Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer. , 2016, Advanced drug delivery reviews.

[62]  R. Parshad,et al.  Search for "indicators" of neoplastic conversion in vitro. , 1967, Journal of the National Cancer Institute.

[63]  Y. Harazono,et al.  Galectin-3 Inhibits Osteoblast Differentiation through Notch Signaling12 , 2014, Neoplasia.

[64]  P. Mehdipour,et al.  Genetics of breast cancer bone metastasis: a sequential multistep pattern , 2014, Clinical & Experimental Metastasis.

[65]  J. Chirgwin,et al.  Molecular biology of bone metastasis. , 2008, Molecular cancer therapeutics.

[66]  K. Hess,et al.  Estrogen Receptors and Distinct Patterns of Breast Cancer Relapse , 2003, Breast Cancer Research and Treatment.

[67]  R. Kappelhoff,et al.  Microarray and Proteomic Analysis of Breast Cancer Cell and Osteoblast Co-cultures , 2011, The Journal of Biological Chemistry.

[68]  Eithne Costello,et al.  From mice to men: Murine models of colorectal cancer for use in translational research. , 2016, Critical reviews in oncology/hematology.

[69]  P. Hauschka,et al.  Notch3 in human breast cancer cell lines regulates osteoblast-cancer cell interactions and osteolytic bone metastasis. , 2010, The American journal of pathology.

[70]  Michael T Lewis,et al.  Patient-derived xenograft models of breast cancer and their predictive power , 2015, Breast Cancer Research.

[71]  R. Coleman Skeletal complications of malignancy , 1997, Cancer.

[72]  D. Lacey,et al.  Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors , 1999, Journal of cellular biochemistry.

[73]  G. Dubini,et al.  Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation , 2014, Proceedings of the National Academy of Sciences.

[74]  Stephen T. C. Wong,et al.  The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells. , 2015, Cancer cell.

[75]  P. De Luca,et al.  Direct but not indirect co-culture with osteogenically differentiated human bone marrow stromal cells increases RANKL / OPG ratio in human breast cancer cells generating bone metastases , 2014 .

[76]  Z. Yao,et al.  Effect of truncated neurokinin‐1 receptor expression changes on the interaction between human breast cancer and bone marrow‐derived mesenchymal stem cells , 2014, Genes to cells : devoted to molecular & cellular mechanisms.

[77]  Anna V. Taubenberger,et al.  In vitro microenvironments to study breast cancer bone colonisation. , 2014, Advanced drug delivery reviews.

[78]  G. Dubini,et al.  A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone. , 2014, Biomaterials.

[79]  J. Massagué,et al.  Metastatic colonization by circulating tumour cells , 2016, Nature.

[80]  Chiang-Ching Huang,et al.  Identification of estrogen-responsive genes involved in breast cancer metastases to the bone , 2007, Clinical & Experimental Metastasis.

[81]  T. Kipps,et al.  CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. , 2006, Blood.

[82]  N. Morrison,et al.  MCP-1 Is Induced by Receptor Activator of Nuclear Factor-κB Ligand, Promotes Human Osteoclast Fusion, and Rescues Granulocyte Macrophage Colony-stimulating Factor Suppression of Osteoclast Formation* , 2005, Journal of Biological Chemistry.

[83]  Jian Lu,et al.  Differential TGFβ pathway targeting by miR-122 in humans and mice affects liver cancer metastasis , 2016, Nature Communications.

[84]  H. Qin,et al.  Calcitonin Gene-Related Peptide Inhibits Osteolytic Factors Induced by Osteoblast In Co-Culture System with Breast Cancer , 2014, Cell Biochemistry and Biophysics.

[85]  D. Venzon,et al.  Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer , 2010, Journal of cellular biochemistry.

[86]  R. Sutherland,et al.  Direct Crosstalk Between Cancer and Osteoblast Lineage Cells Fuels Metastatic Growth in Bone via Auto‐Amplification of IL‐6 and RANKL Signaling Pathways , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.